OTCMKTS:TRSSFTerrascend Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Terrascend Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $2.17 +0.10 (+4.82 %) (As of 07/9/2020 04:00 PM ET) Add Compare Share Today's Range$2.11Now: $2.17▼$2.2650-Day Range$1.92MA: $2.20▼$2.4952-Week Range$1.19Now: $2.17▼$5.37Volume63,800 shsAverage Volume86,255 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsHeadlinesSocial Media TerrAscend Corp., a biopharmaceutical and wellness company, engages in the cultivation, development, and sale of medical cannabis in Canada. The company offers its cannabis products under the Knüba Naturals brand. It also provides education and support programs to physicians and patients through health care professionals. The company was incorporated in 2017 and is based in Mississauga, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Terrascend. Previous Next 4.1 Community Rank Outperform VotesTerrascend has received 37 “outperform” votes. (Add your “outperform” vote.)Underperform VotesTerrascend has received 8 “underperform” votes. (Add your “underperform” vote.)Community SentimentTerrascend has received 82.22% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Terrascend and other stocks. Vote “Outperform” if you believe TRSSF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TRSSF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldTerrascend does not currently pay a dividend.Dividend GrowthTerrascend does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Terrascend insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.82 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:TRSSF Previous Symbol CUSIPN/A CIKN/A Webwww.terrascend.com Phone855-837-7295Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable OTC:TRSSF Rates by TradingView Receive TRSSF News and Ratings via Email Sign-up to receive the latest news and ratings for TRSSF and its competitors with MarketBeat's FREE daily newsletter. Terrascend (OTCMKTS:TRSSF) Frequently Asked Questions How has Terrascend's stock been impacted by COVID-19 (Coronavirus)? Terrascend's stock was trading at $1.8277 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, TRSSF shares have increased by 18.9% and is now trading at $2.1730. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Terrascend? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Terrascend in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Terrascend. Has Terrascend been receiving favorable news coverage? News headlines about TRSSF stock have trended somewhat negative this week, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Terrascend earned a media sentiment score of -1.6 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the near term. View the latest news about Terrascend. Who are some of Terrascend's key competitors? Some companies that are related to Terrascend include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF), Cipher Pharmaceuticals (CPHRF) and CLS Holdings USA (CLSH). View all competitors. Who are Terrascend's key executives? Terrascend's management team includes the following people: Dr. Michael Nashat, Founder, CEO, COO & Director (Age 35)Mr. Matthew J. Johnson, PresMr. Adam Kozak, Chief Financial OfficerMr. Alex Correia, VP of Corp. Affairs & CommunicationsMs. Dawn Vanek-Mithra, Director of Marketing What is Terrascend's stock symbol? Terrascend trades on the OTCMKTS under the ticker symbol "TRSSF." How do I buy shares of Terrascend? Shares of TRSSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Terrascend's stock price today? One share of TRSSF stock can currently be purchased for approximately $2.17. What is Terrascend's official website? The official website for Terrascend is www.terrascend.com. How can I contact Terrascend? The company can be reached via phone at 855-837-7295. This page was last updated on 7/9/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
